Norway's Medistim Q3 revenue rises 25.9% on Americas strength
Norway's Medistim Q3 revenue rises 25.9% on Americas strength
Overview
Norway medical device maker's Q3 revenue rose 25.9% yr/yr to record MNOK 210.0
Q3 operating profit grew 55.7% yr/yr, with EBIT margin rising to 30.1%
Company declared quarterly dividend of NOK 2.50 per share
Outlook
Medistim did not provide specific guidance for future quarters or the full year in its press release
Result Drivers
OWN PRODUCTS SALES - Co said currency neutral sales of own products grew 34.6% in Q3, driving overall revenue growth
REGIONAL GROWTH - Co reported strong currency neutral sales growth in Americas (up 51.7%), APAC (up 44.6%) and EMEA (up 5.5%) in Q3
THIRD-PARTY SALES - Co said third-party distributor sales in Scandinavia increased 5.3% in Q3 but declined 13.0% YTD September
Company press release: ID:nObir1jJha
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue |
| NOK 210 mln |
|
Q3 EBIT |
| NOK 63.1 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Medistim ASA is NOK332.50, about 18.3% above its October 22 closing price of NOK281.00
The stock recently traded at 29 times the next 12-month earnings vs. a P/E of 28 three months ago
Reuters Recommended Reads
Oct 23 - Boule Diagnostics Q3 sales fall on weak instrument demand
Oct 22 - Sweden's Arjo Q3 revenue beats estimates, gross margin expands
Oct 22 - Sweden's XVIVO Q3 revenue beat expectations on thoracic sales
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)